Real-life effectiveness of transitioning from paliperidone palmitate 1-monthly to paliperidone palmitate 3-monthly long-acting injectable formulation

Olivier Corbeil, Anne Marie Essiambre, Laurent Béchard, Audrey Anne Roy, Maxime Huot-Lavoie, Sébastien Brodeur, Ranjith Chandrasena, Chantale Thériault, Candice Crocker, Jean Pierre Melun, Phil Tibbo, Marie France Demers, Marc André Roy

科研成果: 期刊稿件 › 文章 › 同行评审

5 引用 （Scopus）
源语言英语
期刊Therapeutic Advances in Psychopharmacology
卷12
DOI
出版状态已出版 - 2022
已对外发布是

!!!ASJC Scopus Subject Areas

  • 心理学（杂项）
  • 药理学、毒理学和药学（杂项）

访问文件

其它文件与链接

指纹

探究 'Real-life effectiveness of transitioning from paliperidone palmitate 1-monthly to paliperidone palmitate 3-monthly long-acting injectable formulation' 的科研主题。它们共同构成独一无二的指纹。
查看全指纹

引用此

Corbeil, O., Essiambre, A. M., Béchard, L., Roy, A. A., Huot-Lavoie, M., Brodeur, S., Chandrasena, R., Thériault, C., Crocker, C., Melun, J. P., Tibbo, P., Demers, M. F., & Roy, M. A. (2022). Real-life effectiveness of transitioning from paliperidone palmitate 1-monthly to paliperidone palmitate 3-monthly long-acting injectable formulation. Therapeutic Advances in Psychopharmacology, 12. https://doi.org/10.1177/20451253221136021